Evidence map›Paper›PMID 37259539›Full record

ArticleHaematologica2023

Intestinal IgA-positive plasma cells are highly sensitive indicators of alloreaction early after allogeneic transplantation and associate with both graft-versus-host disease and relapse-related mortality.

Lucia Scheidler, Katrin Hippe, Sakhila Ghimire, Daniela Weber, Markus Weber, Elisabeth Meedt, Petra Hoffmann, Petra Lehn, Ralph Burkhardt, Andreas Mamilos and 7 more

Open access · goldAbstract read
In one paragraph

Article in Haematologica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Graft-Versus-Host Disease Mouse Models: A Clinical-Translational Perspective.Methods in molecular biology (Clifton, N.J.) · 2025
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 1 country.

Lucia ScheidlerDepartment of Internal Medicine 3 (Hematology/Oncology), University Hospital, Regensburg.
Katrin HippeDepartment of Pathology, University of Regensburg, Regensburg.
Sakhila GhimireDepartment of Internal Medicine 3 (Hematology/Oncology), University Hospital, Regensburg.
Daniela WeberDepartment of Pathology, University of Regensburg, Regensburg.
Markus WeberDepartment of Trauma, Orthopaedics and Sports Surgery, Barmherzige Brueder Regensburg.
Elisabeth MeedtDepartment of Internal Medicine 3 (Hematology/Oncology), University Hospital, Regensburg.
Petra HoffmannDepartment of Internal Medicine 3 (Hematology/Oncology), University Hospital, Regensburg, Germany; Leibniz-Institute for Immunotherapy (LIT), Regensburg.
Petra LehnDepartment of Clinical Chemistry and Laboratory Medicine, University Hospital, Regensburg.
Ralph BurkhardtDepartment of Clinical Chemistry and Laboratory Medicine, University Hospital, Regensburg.
Andreas MamilosDepartment of Pathology, University of Regensburg, Regensburg.
Matthias EdingerDepartment of Internal Medicine 3 (Hematology/Oncology), University Hospital, Regensburg, Germany; Leibniz-Institute for Immunotherapy (LIT), Regensburg.
Daniel WolffDepartment of Internal Medicine 3 (Hematology/Oncology), University Hospital, Regensburg.
Hendrik PoeckDepartment of Internal Medicine 3 (Hematology/Oncology), University Hospital, Regensburg, Germany; Leibniz-Institute for Immunotherapy (LIT), Regensburg.
Matthias EvertDepartment of Pathology, University of Regensburg, Regensburg.
Andre GessnerDepartment of Medical Microbiology and Hygiene, University Hospital Regensburg.
Wolfgang HerrDepartment of Internal Medicine 3 (Hematology/Oncology), University Hospital, Regensburg.
Ernst HollerDepartment of Internal Medicine 3 (Hematology/Oncology), University Hospital, Regensburg. ernst.holler@ukr.de.
University Hospital Regensburg · DEUniversity of Regensburg · DELeibniz Institute for ImmunotherapyInstitute of Medical Microbiology and Hygiene · DEKrankenhaus Barmherzige Brüder · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intestinal immunoglobulin A (IgA) is strongly involved in microbiota homeostasis. Since microbiota disruption is a major risk factor of acute graft-versus-host disease (GvHD), we addressed the kinetics of intestinal IgA-positive (IgA+) plasma cells by immunohistology in a series of 430 intestinal biopsies obtained at a median of 1,5 months after allogeneic stem cell transplantation (allo-SCT) from 115 patients (pts) at our center. IgA+ plasma cells were located in the subepithelial lamina propria and suppressed in the presence of histological aGvHD (GvHD Lerner stage 0: 131+/-8 IgA+ plasma cells/mm2; stage 1-2: 108+/-8 IgA+ plasma cells/mm2; stage 3-4: 89+/-16 IgA+ plasma cells/mm2; P=0.004). Overall, pts with IgA+ plasma cells below median had an increased treatment related mortality (P=0.04). Time courses suggested a gradual recovery of IgA+ plasma cells after day 100 in the absence but not in the presence of GvHD. Vice versa IgA+ plasma cells above median early after allo-SCT were predictive of relapse and relapse-related mortality (RRM): pts with low IgA+ cells had a 15% RRM at 2 and at 5 years, while pts with high IgA+ cells had a 31% RRM at 2 years and more than 46% at 5 years; multivariate analysis indicated high IgA+ plasma cells in biopsies (hazard ratio =2.7; 95% confidence interval: 1.04-7.00) as independent predictors of RRM, whereas Lerner stage and disease stage themselves did not affect RRM. In contrast, IgA serum levels at the time of biopsy were not predictive for RRM. In summary, our data indicate that IgA+ cells are highly sensitive indicators of alloreaction early after allo-SCT showing association with TRM but also allowing prediction of relapse independently from the presence of overt GvHD.

Indexed as

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationChronic DiseaseHumansImmunoglobulin APlasma CellsRecurrenceTransplantation, HomologousImmunoglobulin A

Identifiers

PMID37259539
PMCPMC10620570
OpenAlexW4378953192

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.